Gout
Naproxen better first-line gout option than colchicine in primary care
Although there is no significant difference between naproxen and low-dose colchicine in terms of improvements in pain intensity among patients with gout flare, naproxen causes fewer side effects, making it the superior first-line option for gout flares in primary care, according to findings published in Annals of the Rheumatic Diseases.
Gout linked to increased cardiovascular disease risk
COLCOT: Low-dose colchicine reduces CV risk after MI
PHILADELPHIA — Adults with a recent MI were less likely to experience an ischemic CV event over 2 years when assigned the anti-inflammatory gout medication colchicine compared with assignment to placebo, according to new results of the COLCOT trial presented at the American Heart Association Scientific Sessions.
Gout guidelines call for treat-to-target strategy using allopurinol
Opioid-related hospitalizations surge for rheumatic diseases, rise led by OA, fibromyalgia, RA
ATLANTA — The incidence of opioid-related hospitalizations among patients with musculoskeletal conditions increased markedly over the past 2 decades, with continued growth among patients with osteoarthritis, rheumatoid arthritis and fibromyalgia, according to a presentation at the 2019 ACR/ARP Annual Meeting.
VIDEO: Patients who develop gout after transplantation more likely to return to dialysis
WASHINGTON — At ASN Kidney Week, Abdul A. Abdellatif, MD, FASN, presented results that assessed the relationship between gout and return to hemodialysis among patients who had a kidney transplant. Researchers found patients who developed gout after transplantation were more likely to need maintenance hemodialysis compared with patients without gout and those with preexisting gout.
VIDEO: Patients with gout at increased risk of transplant-related complications
ACR to expand use of livestreams, add 'TED Talk-style' sessions for 2019 annual meeting
The American College of Rheumatology plans to expand its digital offerings at the 2019 ACR/ARP Annual meeting this weekend with more than 50 sessions available for livestreaming, along with a new “TED Talk-style” collection of short lectures set to tackle several “controversial issues facing rheumatologists today,” according to organizers.